International Consultants

Grace Dy, MD

Associate Professor, Department of Medicine, Roswell Park Cancer Institute

Areas of Expertise:

Lung cancer
Mesothelioma
Thymic malignancies

Special Interests:

Phase I clinical trials
Novel targets for lung cancer therapy

Board Certification:

Hematology, American Board of Internal Medicine
Internal Medicine, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine

Fellowship:

Mayo Clinic College of Medicine, Rochester, MN

Residency:

Mayo Clinic College of Medicine, Rochester, MN

Education and Training:

MD – University of Santo Tomas, Manila, Philippines

Renuka Iyer, MD

Associate Professor of Oncology, Co-Director, Liver and Pancreas Tumor Center, IL-2 Program, Roswell Park Cancer Institute

Assistant Professor of Medicine, Section Chief for Gastrointestinal Oncology, School of Medicine and Biomedical Sciences, State University of New York at Buffalo

Areas of Expertise:

Bile duct cancer
Carcinoid
Cholangiocarcinoma
Esophageal cancer
Hepatocellular cancer
Pancreatic cancer

Special Interests:

Developing novel treatments for patients with hepatocellular, pancreaticobiliary and neuroendocrine cancers
Studies of novel targeted therapies in a woodchuck model of liver cancer
Understanding the mechanism of the anticancer effects of vitamin D
Board Certification:

Board Certification:

Internal Medicine, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine

Fellowship:

Roswell Park Cancer Institute, Buffalo, NY

Residency:

Lincoln Medical and Mental Health Center, Cornell University, New York, NY

Education and Training:

Grant Medical College, University of Mumbai, Maharashtra, India

Nikhil Khushalani, MD

Areas of Expertise:

Melanoma
Sarcoma
Gastrointestinal stromal tumors (GIST)
Biological therapy in cancer

Special Interests:

Investigation of novel therapeutics, including anti-angiogenics in melanoma and sarcoma
Investigate immunotherapy approaches for melanoma
Identify predictors of response to high-dose Interleukin-2 biotherapy

Board Certification:

Internal Medicine, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine

Fellowship:

Roswell Park Cancer Institute, Buffalo, NY

Residency:

School of Medicine and Biomedical Sciences, State University of New York at Buffalo

Medical Education and Training:

MD – Topiwala National Medical College, University of Mumbai, Maharashtra, India

Dr. Tracey O’Connor

Areas of Expertise:

Breast Cancer

Special Interests:

Novel treatments for breast cancer
Psychological impact of breast cancer
Supportive care therapies for patients with advanced disease
Survivorship issues and breast cancer

Board Certification:

Internal Medicine, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine

Fellowship:

Roswell Park Cancer Institute, Buffalo, NY

Residency:

Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY

Education and Training:

MD – School of Medicine and Biomedical Sciences, State University of New York at Buffalo
BS – Northwestern University, Evanston, IL

Francisco Hernandez-Ilizaliturri, MD

Areas of Expertise:

Lymphoma
Multiple myeloma

Special Interests:

Mechanisms associated with resistance to monoclonal antibodies in lymphoma patients
Developing new strategies to enhance the activity of therapies such as rituximab and other monoclonal antibodies

Board Certification:

Internal Medicine, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine

Fellowship:

Roswell Park Cancer Institute, Buffalo, NY

Residency:

School of Medicine and Biomedical Sciences, State University of New York at Buffalo

Medical Education and Training:

MD – InstitutoTecnologico y de Estudio Superiores de Monterrey, Monterrey, Mexico

Saby George, MD, FACP

Areas of Expertise:

Kidney Cancer
Prostate Cancer
Bladder Cancer

Special Interests:

Kidney cancer: clinical trials, novel drug development, mechanism of resistance formation to tyrosine kinase inhibitors, immunotherapy, improving the response evaluation criteria and development of biomarkers.

Prostate cancer: Castrate refractory prostate cancer, high Gleason score disease, improving androgen deprivation therapy and biomarker development.

Board Certification:

Internal Medicine, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine

Fellowship:

Experimental therapeutics-Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
Medical Oncology-University of Texas Health Sciences Center at San Antonio, San Antonio, TX

Residency:

Wright State University, Dayton, OH

Medical Education and Training:

Kottayam Medical College, Kerala, India